Advertisement

Topics

Hatteras Venture Partners Company Profile

03:26 EST 16th December 2018 | BioPortfolio

Hatteras Venture Partners (HVP) is a venture capital firm based in Research Triangle Park, NC with a focus on seed and early stage opportunities in biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine.


News Articles [365 Associated News Articles listed on BioPortfolio]

Kymera closes $65mm Series B round

Kymera Therapeutics Inc. (protein degradation-based drug discovery) raised $65mm through its Series B round. Bessemer Venture Partners, 6 Dimensions Capital, and Pfizer Venture Investments co-led and ...

Qpex spins off from TMC, raises $33mm in Series A round

Qpex Biopharma Inc. spun off from the The Medicines Co. (TMC) raising $33mm in its Series A financing led by New Enterprise Associates, which was joined by Adams Street Partners, LYZZ Capital, Hattera...

StrideBio gets $15.7mm via Series A

StrideBio Inc. (developing novel adeno-associated viral (AAV) vectors for in vivo gene therapies aimed at rare diseases) raised $15.7mm in an oversubscribed Series A financing led by Hatteras Venture ...

Series A lands $30mm for Ribometrix

Ribometrix Inc. (small-molecule therapies targeting RNA) raised $30mm in its Series A financing led by M Ventures, which adds a board member and was joined by first-time backers Amgen Ventures, Pappas...

Series D brings in $34mm for PhaseBio

PhaseBio Pharmaceuticals Inc. (orphan disease therapies) closed on a $34mm Series D financing to first-time backers Cormorant Asset Management, Rock Springs Capital, and Mountain Group Partners, and r...

Series B brings in $40mm for OncoResponse

OncoResponse Inc. (cancer immunotherapies) raised $40mm through its Series B round, which was led by RiverVest Venture Partners and included investments by first-time buyers Qatar Investment Authority...

GBS Venture Partners: Joshua Funder on seeing positive signs in the Australian biotech sector.

In this episode of PharmaTelevision News Review, Fintan Walton talks to Joshua Funder, Partner at GBS Venture Partners

Series B lands $70mm for Akero

Just six months after its $65mm Series A financing, Akero Therapeutics Inc. has now raised $70mm through a Series B round led by Janus Henderson Investors, which was joined by other first-time backers...

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Sweatblock [DC Alpine Partners, LLC DBA: Sweatblock]

SWEATBLOCK Clinical Strength Antiperspirant

Day cream mattifying hydrator [MOSAIC MARKETING PARTNERS LLC]

DAY CREAM MATTIFYING HYDRATOR

Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

PubMed Articles [258 Associated PubMed Articles listed on BioPortfolio]

Impact of HIV Self-Test Distribution to Male Partners of ANC Clients: Results of a Randomized Controlled Trial in Kenya.

In Kenya, HIV testing during first ANC visit is standard practice for pregnant women. Despite a policy promoting male partner testing in ANC, few male partners accompany their partners for HIV testing...

Trust, Money, and Power: Life Cycle Dynamics in Alliances Between Management Partners and Accountable Care Organizations.

Policy Points Accountable care organizations (ACOs) form alliances with management partners to access financial, technical, and managerial support. Alliances between ACOs and management partners are s...

Prevalence of HIV infection, access to HIV care, and response to antiretroviral therapy among partners of HIV-infected individuals in Thailand.

Health care providers usually focus on index HIV-infected patients and seldom obtain information from their partners. We aimed to determine HIV-preventative measures among couples, the prevalence of H...

A Misguided Venture: Presidential Fitness and the Duty to Warn.

Commentary on "A Misguided Venture: Presidential Fitness and the Duty to Warn".

Clinical Trials [340 Associated Clinical Trials listed on BioPortfolio]

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Teachers and Parents as Partners During Middle School RCT

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

This pilot clinical trial studies how well acceptance and commitment therapy works in improving well-being in patients with stage III-IV cancer and their partners. Learning how to accept n...

Companies [1650 Associated Companies listed on BioPortfolio]

Hatteras Venture Partners

Hatteras Venture Partners (HVP) is a venture capital firm based in Research Triangle Park, NC with a focus on seed and early stage opportunities in biopharmaceuticals, medical dev...

AgTech Accelerator

AgTech Accelerator, established in 2016 in Research Triangle Park, is a venture development organization focused on discovering and developing emerging agricultural technology and...

Coferon, Inc.

Coferon is an angel and venture-backed company with a syndicate led by Hatteras Venture Partners and Ascent Biomedical Venture Partners formed to exploit the novel and potentially...

Clearside Biomedical

Clearside Biomedical is an ophthalmic company specializing in the research, development and commercialization of therapeutic products through a proprietary ocular microinjection p...

Stromedix, Inc.

Stromedix is a privately held biotechnology company based in Cambridge, Massachusetts, focused on innovative therapies for fibrotic organ failure. Investors in Stromedix include A...

More Information about "Hatteras Venture Partners" on BioPortfolio

We have published hundreds of Hatteras Venture Partners news stories on BioPortfolio along with dozens of Hatteras Venture Partners Clinical Trials and PubMed Articles about Hatteras Venture Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hatteras Venture Partners Companies in our database. You can also find out about relevant Hatteras Venture Partners Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record